Argenx Secures $1.1 Billion in Funding Following Successful CIDP Trial

Argenx Secures $1.1 Billion in Funding Following Successful CIDP Trial

Following a significant breakthrough with its star drug Vyvgart Hytrulo, argenx, a biopharmaceutical company, has successfully raised over $1 billion…